Is AQST or BGM more undervalued in 2026?

CirclFi compares Aquestive Therapeutics, Inc. (AQST) and BGM Group Ltd. (BGM) using 13 institutional-grade valuation models. AQST has a Quality of Company score of 5.7/10 while BGM scores 2.2/10.

Which is a better buy — AQST or BGM?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AQST and BGM valuations compare?

AQST at $4.02 and BGM at $0.32 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AQST vs BGM Valuation Comparison 2026 — Intrinsic Value Analysis

AQST

Drug Manufacturers - Specialty & Generic

Aquestive Therapeutics, Inc.

Quality

5.7

out of 10

Value Trap

LOW

Price

$4.02

Last close

Models

10/13

Active

BGM

Drug Manufacturers - Specialty & Generic

BGM Group Ltd.

Quality

2.2

out of 10

Value Trap

—

Price

$0.32

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	AQST Fair Value	AQST Upside	BGM Fair Value	BGM Upside
Bayesian DCF	Intrinsic	$1.37	-66.0%	$0.06	-80.1%
Earnings Power Value	Intrinsic	$1.22	-70.9%	$0.02	-92.1%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AQST vs BGM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AQST vs BGM — Which Stock Is More Undervalued?

AQST scores higher with a 5.7/10 quality rating vs BGM's 2.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aquestive Therapeutics, Inc. (AQST) and BGM Group Ltd. (BGM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AQST currently trades at $4.02 with a QOC of 5.7/10, while BGM trades at $0.32 with a QOC of 2.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).